Who has invested in Belenos Biosciences?

OrbiMed are named among the investors backing Belenos Biosciences.

Belenos Biosciences Funding: $48M Raised, Series A (2024)

Belenos Biosciences funding overview

Belenos Biosciences is based in New York, NY. Belenos Biosciences has raised $48M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2024. The round record for Belenos Biosciences runs through 2024; nothing later has been disclosed. Investors on record include OrbiMed.

Belenos Biosciences at a glance

Total raised: $48M
Latest round: Series A
Latest round date: July 2024
Headquarters: New York, NY
Notable investors: OrbiMed

Frequently asked about Belenos Biosciences funding

How much has Belenos Biosciences raised?: Belenos Biosciences has raised $48M in total disclosed funding across the rounds on record.
Who has invested in Belenos Biosciences?: OrbiMed are named among the investors backing Belenos Biosciences.
What was the latest Belenos Biosciences funding round?: The most recent disclosed round is a Series A, announced in July 2024.
Where is Belenos Biosciences based?: Belenos Biosciences is based in New York, NY.
When did Belenos Biosciences last raise?: The last disclosed Belenos Biosciences round closed in July 2024 at Series A.

Belenos Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York below to benchmark round size and investor mix.

Belenos Biosciences Funding: $48M Raised, Series A (2024)

Belenos Biosciences funding overview

Belenos Biosciences at a glance

Frequently asked about Belenos Biosciences funding

Companies related to Belenos Biosciences (36)

Browse related funding lists (5)